CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
D000157:Aconitine / Q000037:antagonists & inhibitors; D000200:Action Potentials / Q000187:drug effects; D000284:Administration, Oral; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D010042:Ouabain / Q000037:antagonists & inhibitors; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D010880:Piperidines; D010042:Ouabain; C024318:pirmenol; D000157:Aconitine; D004837:Epinephrine